A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...
Kidney disease is a major global health issue with implications for the lives of millions of people and for the cost of health care. Yet there is surprisingly little public awareness about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results